BioImaging Technologies: Global Strategic Business Report

Global BioImaging Technologies Market to Reach $28.2 Billion by 2030

The global market for BioImaging Technologies estimated at US$10.3 Billion in the year 2022, is projected to reach a revised size of US$28.2 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2022-2030. Medical, one of the segments analyzed in the report, is projected to record 13% CAGR and reach US$17.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Molecular segment is readjusted to a revised 14.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 12.7% CAGR

The BioImaging Technologies market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 12.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 10.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.

Select Competitors (Total 14 Featured) -

• BioClinica
• Bracco Imaging SpA
• Digirad Corporation
• Esaote SpA
• Fonar Corporation
• FUJIFILM SonoSite, Inc.
• GE Healthcare
• Hitachi, Ltd.
• Medtronic, Inc.
• Philips Healthcare
• Positron Corporation
• Siemens Healthineers

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year